Literature DB >> 26676378

Midwifery Provision of Home Birth Services: American College of Nurse-Midwives.

.   

Abstract

The number of women in the United States choosing to give birth at home has risen substantially in the past decade, creating an increased need for understanding of the evidence regarding the provision of midwifery care to women and families considering this option. The safety of home birth has been evaluated in observational studies in several industrialized nations, including the United States. Most studies find that women who are essentially healthy at term with a singleton fetus and give birth at home have positive outcomes and a lower rate of interventions during labor. Although some studies have found increased neonatal morbidity and mortality in newborns born at home when compared to newborns born in a hospital, the absolute numbers reported in both birth sites are very low. The purpose of this clinical bulletin is to review the evidence on provision of care to women and families who plan to give birth at home, including roles and responsibilities, shared decision making, informed consent, and ongoing assessment for birth site selection.
© 2015 by the American College of Nurse-Midwives.

Entities:  

Keywords:  home childbirth; midwifery; shared decision making

Mesh:

Year:  2015        PMID: 26676378     DOI: 10.1111/jmwh.12431

Source DB:  PubMed          Journal:  J Midwifery Womens Health        ISSN: 1526-9523            Impact factor:   2.388


  2 in total

Review 1.  A Comparative Workforce Study of Midwives Practicing in the State of Texas.

Authors:  Rebecca H Burpo; Priscilla M Nodine; Marie Hastings-Tolsma; Mary C Brucker; Jackie Griggs; Sarah Wilcox; Barbara D Camune; Tiffany Callahan
Journal:  J Midwifery Womens Health       Date:  2018-06-08       Impact factor: 2.388

2.  Interest in Home Birth During the COVID-19 Pandemic: Analysis of Google Trends Data.

Authors:  Ru-Fong J Cheng; Alan C Fisher; Susan C Nicholson
Journal:  J Midwifery Womens Health       Date:  2022-03-10       Impact factor: 2.891

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.